Health
This small Canadian drugmaker wants to make J&J vaccines for poor nations. It needs more than a patent waiver. – News-Medical.Net
Biolyse Pharma Corp., which makes a cancer medication, was gearing up to start making generic biologic drugs, made from living organisms. Then the pandemic hit.
Biolyse Pharma Corp., which makes a cancer medication, was gearing up to start making generic biologic drugs, made from living organisms. Then the pandemic hit.
Watching the covid death toll climb, the company decided its new production lines and equipment could be converted to making vaccines for poorer countries without the means to do so.
John Fulton, a consultant for the Canadian company, emailed Janssen, the Johnson & Johnson subsidiary that makes the vaccine, which employs a live, though disabled,…
-
General11 hours agoFarmers develop ‘autofill’ tech so agricultural robots can operate around the clock
-
Noosa News17 hours agoRevealed: 75 Qld suburbs you could afford to buy in if lending standards drop
-
General23 hours agoLiberals offer help to start-ups and set goal for small business growth
-
Business16 hours agoWhere to invest $20,000 into ASX 200 shares after the market selloff